Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  • Computer games give a boost to English

  • How nerve cells communicate with each other over long distances: Travelling by resonance

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Marijuana compound may offer treatment for Alzheimer's disease, study suggests

  • Gang life brings deep health risks for girls

  • First study of brain activation in multiple sclerosis using fNIRS

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  • Avatars make the Internet sign to deaf people

  •